| Issue |
Section |
Title |
File |
| Vol 11, No 3 (2014) |
Articles |
The results of the open observational, international, multicenter, prospective program to assess the efficacy, safety and tolerability of the first direct renin inhibitor RasilezR (aliskiren) in patients with arterial hypertension in ‘real-life’ clinical practice settings (DRIve) |
 (Rus)
|
| Vol 11, No 3 (2014) |
Articles |
Education and self-education of the patients is an important step towards increasing patients acceptance of therapy |
 (Rus)
|
| Vol 11, No 4 (2014) |
Articles |
Methods of sympathetic activity evaluation in patients with systemic refractory hypertension |
 (Rus)
|
| Vol 11, No 4 (2014) |
Articles |
Role of the Pulse Oximetry in the cardiologist's practice |
 (Rus)
|
| Vol 11, No 4 (2014) |
Articles |
The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk |
 (Rus)
|
| Vol 11, No 4 (2014) |
Articles |
The state of the vascular wall in adult population of Tomsk in the framework of the project ESSAY RF |
 (Rus)
|
| Vol 11, No 4 (2014) |
Articles |
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders |
 (Rus)
|
| Vol 14, No 4 (2017) |
Articles |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V |
 (Rus)
|
| Vol 14, No 3 (2017) |
Articles |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I |
 (Rus)
|
| Vol 14, No 3 (2017) |
Articles |
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level |
 (Rus)
|
| Vol 14, No 3 (2017) |
Articles |
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders |
 (Rus)
|
| Vol 15, No 1 (2018) |
Articles |
Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI-VII |
 (Rus)
|